Eisai Innovation Inc.

Funding rounds backed by Eisai Innovation Inc..

Export CSV
Funding disclosed in full
$50M
Median round
$50M
Rounds in calculation
1
1 round
LatestLargest
Funding rounds with company descriptions, amounts, stages and announcement dates
CompanyRoundMarketInvestorsAnnouncedDetails
Vivacta Biotechnology

Develops in vivo CAR-T cell therapies for cancer and autoimmune diseases

$50MSeries A+BiotechChina
9 participantsApricot CapitalBeijing ShunxiC&D Emerging Industry Equity InvestmentDecheng CapitalEisai Innovation Inc.HanKang CapitalLoyal Valley CapitalOrbiMedQiming Venture Partners